the niome angle people sleep on: synthetic data that's actually differentially private is hard, and for pharma/clinical use the bar is regulatory, not vibes. if the synthetic set leaks membership you've built a very expensive liability. curious what epsilon they target and whether it's per-record or per-dataset. that number is basically the whole product.